See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2015_Biomarin_Pharmaceutical_INC.pdf
Logs
Graph
Absolute values for 0001048477, Biomarin Pharmaceutical INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,425,629,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 210,836,000 |
| 2 | PropertyPlantAndEquipmentNet | 523,516,000 |
| 3 | remainder_Assets | 330,472,000 |
| 4 | LiabilitiesCurrent | 235,739,000 |
| 5 | LiabilitiesNoncurrent | 30,077,000 |
| 6 | remainder_Liabilities | 696,743,000 |
| 7 | CostOfGoodsAndServicesSold | 140,356,451 |
| 8 | SellingGeneralAndAdministrativeExpense | 329,773,343 |
| 9 | ResearchAndDevelopmentExpense | 674,975,294 |
| 10 | remainder_Expenses | 12,443,012 |
| 11 | remainder_Revenues | 825,673,601 |
| 12 | remainder_NetIncome | 5,873,322 |
| 13 | remainder_ComprehensiveNetIncome | 95,775,754 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,490,453,000 |
| 1 | Liabilities | 962,559,000 |
| 2 | Expenses | 1,157,548,100 |
| 3 | Revenues | 825,673,601 |
| 4 | StockholdersEquity | 1,527,894,000 |
| 5 | NetIncome | -326,001,177 |
| 6 | ComprehensiveNetIncome | -278,113,300 |
| 7 | BaseVar | 2,768,941,388 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.77 |
| 9 | EconomicCapitalRatio | 2.87 |
Edgar->Model Mapping
Feature Distribution
Change over Time
